The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Applications of nanotechnology for immunology
Open accessAbstract
Nanotechnology uses the unique properties of objects that function as a unit within the overall size range of 1–1,000 nanometres. The engineering of nanostructure materials, including nanoparticles, nanoemulsions or nanotubules, holds great promise for the development of new immunomodulatory agents, as such nanostructures can be used to more effectively manipulate or deliver immunologically active components to target sites. Successful applications of nanotechnology in the field of immunology will enable new generations of vaccines, adjuvants and immunomodulatory drugs that aim to improve clinical outcomes in response to a range of infectious and non-infectious diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid
WATSON, J. D., & CRICK, F. H. C. (1953) · Nature · doi:10.1038/171737a0 · Cited by 13,584
Haine, M. M.-L., & Meeùs, N. (1986) · Cited by 3,464
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Bachmann, M. F., & Jennings, G. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2868 · Cited by 2,106
Erickson, H. P. (2009) · Biological Procedures Online · doi:10.1007/s12575-009-9008-x · Cited by 1,571
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Reddy, S. T., van der Vlies, A. J., Simeoni, E., Angeli, V., Randolph, G. J., O'Neil, C. P., Lee, L. K., Swartz, M. A., & Hubbell, J. A. (2007) · Nature Biotechnology · doi:10.1038/nbt1332 · Cited by 1,350
Endotoxin tolerance: new mechanisms, molecules and clinical significance
Biswas, S. K., & Lopez-Collazo, E. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.07.009 · Cited by 1,318
Nanoparticles target distinct dendritic cell populations according to their size
Manolova, V., Flace, A., Bauer, M., Schwarz, K., Saudan, P., & Bachmann, M. F. (2008) · European Journal of Immunology · doi:10.1002/eji.200737984 · Cited by 1,289
Immunogenic and tolerogenic cell death
Green, D. R., Ferguson, T., Zitvogel, L., & Kroemer, G. (2009) · Nature Reviews Immunology · doi:10.1038/nri2545 · Cited by 1,176
Dey, J. P., Alexopoulos, C. J., Mims, C. W., & Blackwell, M. (1996) · The Bryologist · doi:10.2307/3244124 · Cited by 1,117
Mundargi, R. C., Babu, V. R., Rangaswamy, V., Patel, P., & Aminabhavi, T. M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.09.013 · Cited by 1,025
Minireview: Nanoparticles and the Immune System
Zolnik, B. S., González-Fernández, A., Sadrieh, N., & Dobrovolskaia, M. A. (2010) · Endocrinology · doi:10.1210/en.2009-1082 · Cited by 914
The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4
Mata-Haro, V., Cekic, C., Martin, M., Chilton, P. M., Casella, C. R., & Mitchell, T. C. (2007) · Science · doi:10.1126/science.1138963 · Cited by 896
Fullerene derivatives: an attractive tool for biological applications
Bosi, S., Da Ros, T., Spalluto, G., & Prato, M. (2003) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2003.09.005 · Cited by 834
Muller, R. H., & Keck, C. M. (2004) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2004.06.007 · Cited by 819
Dynamic regulatory network controlling TH17 cell differentiation
Yosef, N., Shalek, A. K., Gaublomme, J. T., Jin, H., Lee, Y., Awasthi, A., Wu, C., Karwacz, K., Xiao, S., Jorgolli, M., et al. (2013) · Nature · doi:10.1038/nature11981 · Cited by 682 · cited 1×
“This therefore has facilitated the identification of crucial points in the molecular network that regulates the immune response 121 .”
In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles
Reddy, S. T., Rehor, A., Schmoekel, H. G., Hubbell, J. A., & Swartz, M. A. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.006 · Cited by 679
Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors
Fifis, T., Gamvrellis, A., Crimeen-Irwin, B., Pietersz, G. A., Li, J., Mottram, P. L., McKenzie, I. F. C., & Plebanski, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3148 · Cited by 664
Molecular structure of nucleic acids: A structure for deoxyribose nucleic acid
Watson, J. D., & Crick, F. H. C. (2004) · Resonance · doi:10.1007/bf02834980 · Cited by 656
Crystal Structure of Human Toll-Like Receptor 3 (TLR3) Ectodomain
Choe, J., Kelker, M. S., & Wilson, I. A. (2005) · Science · doi:10.1126/science.1115253 · Cited by 602
Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines
Nochi, T., Yuki, Y., Takahashi, H., Sawada, S.-I., Mejima, M., Kohda, T., Harada, N., Kong, I. G., Sato, A., Kataoka, N., et al. (2010) · Nature Materials · doi:10.1038/nmat2784 · Cited by 468
Dendritic Cells: Immune Regulators in Health and Disease
Lipscomb, M. F., & Masten, B. J. (2002) · Physiological Reviews · doi:10.1152/physrev.00023.2001 · Cited by 465
Calabro, S., Tortoli, M., Baudner, B. C., Pacitto, A., Cortese, M., O’Hagan, D. T., De Gregorio, E., Seubert, A., & Wack, A. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.12.090 · Cited by 433
Pulmonary and Systemic Immune Response to Inhaled Multiwalled Carbon Nanotubes
Mitchell, L. A., Gao, J., Wal, R. V., Gigliotti, A., Burchiel, S. W., & McDonald, J. D. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm196 · Cited by 431
Seubert, A., Monaci, E., Pizza, M., O’Hagan, D. T., & Wack, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5402 · Cited by 430
The global impact of vaccination against hepatitis B: A historical overview
Zanetti, A. R., Van Damme, P., & Shouval, D. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.09.056 · Cited by 420
Dendrimer-Based Postnatal Therapy for Neuroinflammation and Cerebral Palsy in a Rabbit Model
Kannan, S., Dai, H., Navath, R. S., Balakrishnan, B., Jyoti, A., Janisse, J., Romero, R., & Kannan, R. M. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003162 · Cited by 399
Influenza Vaccines for the Future
Lambert, L. C., & Fauci, A. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmra1002842 · Cited by 389
The Role of Antibodies in HIV Vaccines
Mascola, J. R., & Montefiori, D. C. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101256 · Cited by 388
Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation
Shaunak, S., Thomas, S., Gianasi, E., Godwin, A., Jones, E., Teo, I., Mireskandari, K., Luthert, P., Duncan, R., Patterson, S., et al. (2004) · Nature Biotechnology · doi:10.1038/nbt995 · Cited by 331
Adjuvant Properties of Aluminum and Calcium Compounds
Gupta, R. K., Rost, B. E., Relyveld, E., & Siber, G. R. (1995) · Pharmaceutical Biotechnology · doi:10.1007/978-1-4615-1823-5_8 · Cited by 330
Hamouda, T., Myc, A., Donovan, B., Shih, A. Y., Reuter, J. D., & Baker, J. R. (2001) · Microbiological Research · doi:10.1078/0944-5013-00069 · Cited by 325
Mechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in mice
Mitchell, L. A., Lauer, F. T., Burchiel, S. W., & McDonald, J. D. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.151 · Cited by 324
Werninghaus, K., Babiak, A., Groß, O., Hölscher, C., Dietrich, H., Agger, E. M., Mages, J., Mocsai, A., Schoenen, H., Finger, K., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081445 · Cited by 315
Cell size of alveolar macrophages: an interspecies comparison.
Krombach, F., Münzing, S., Allmeling, A. M., Gerlach, J. T., Behr, J., & Dörger, M. (1997) · Environmental Health Perspectives · doi:10.1289/ehp.97105s51261 · Cited by 285
Cruz, L. J., Tacken, P. J., Fokkink, R., Joosten, B., Stuart, M. C., Albericio, F., Torensma, R., & Figdor, C. G. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.013 · Cited by 281
Grun, J. L., & Maurer, P. H. (1989) · Cellular Immunology · doi:10.1016/0008-8749(89)90011-7 · Cited by 281
Hamouda, T., & Baker, J. R. (2000) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.2000.01127.x · Cited by 277
Fullerene Nanomaterials Inhibit the Allergic Response
Ryan, J. J., Bateman, H. R., Stover, A., Gomez, G., Norton, S. K., Zhao, W., Schwartz, L. B., Lenk, R., & Kepley, C. L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.665 · Cited by 273
Dubensky, T. W., & Reed, S. G. (2010) · Seminars in Immunology · doi:10.1016/j.smim.2010.04.007 · Cited by 259
Cationic liposomes as vaccine adjuvants
Christensen, D., Korsholm, K. S., Andersen, P., & Agger, E. M. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.17 · Cited by 259
Hamdy, S., Molavi, O., Ma, Z., Haddadi, A., Alshamsan, A., Gobti, Z., Elhasi, S., Samuel, J., & Lavasanifar, A. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.07.035 · Cited by 252
Promotion of B Cell Immune Responses via an Alum-Induced Myeloid Cell Population
Jordan, M. B., Mills, D. M., Kappler, J., Marrack, P., & Cambier, J. C. (2004) · Science · doi:10.1126/science.1089926 · Cited by 248
Zaks, K., Jordan, M., Guth, A., Sellins, K., Kedl, R., Izzo, A., Bosio, C., & Dow, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7335 · Cited by 242
The dimensions of DNA in solution
Mandelkern, M., Elias, J. G., Eden, D., & Crothers, D. M. (1981) · Journal of Molecular Biology · doi:10.1016/0022-2836(81)90099-1 · Cited by 240
(How) do aluminium adjuvants work?
BREWER, J. (2006) · Immunology Letters · doi:10.1016/j.imlet.2005.08.002 · Cited by 236
Zhang, Z., Tongchusak, S., Mizukami, Y., Kang, Y. J., Ioji, T., Touma, M., Reinhold, B., Keskin, D. B., Reinherz, E. L., & Sasada, T. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.067 · Cited by 228
Schultze, V., D’Agosto, V., Wack, A., Novicki, D., Zorn, J., & Hennig, R. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.03.093 · Cited by 227
Translating Tumor Antigens into Cancer Vaccines
Buonaguro, L., Petrizzo, A., Tornesello, M. L., & Buonaguro, F. M. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00286-10 · Cited by 219
A Novel Surfactant Nanoemulsion with Broad‐Spectrum Sporicidal Activity against Bacillus Species
Hamouda, T., Hayes, M. M., Cao, Z., Tonda, R., Johnson, K., Wright, D. C., Brisker, J., & Baker, J. R. (1999) · The Journal of Infectious Diseases · doi:10.1086/315124 · Cited by 206
Slütter, B., Bal, S., Keijzer, C., Mallants, R., Hagenaars, N., Que, I., Kaijzel, E., van Eden, W., Augustijns, P., Löwik, C., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.06.121 · Cited by 201
Goldinger, S. M., Dummer, R., Baumgaertner, P., Mihic‐Probst, D., Schwarz, K., Hammann‐Haenni, A., Willers, J., Geldhof, C., Prior, J. O., Kündig, T. M., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201142361 · Cited by 201
Effects of Adjuvants on the Safety and Immunogenicity of an Avian Influenza H5N1 Vaccine in Adults
Bernstein, D. I., Edwards, K. M., Dekker, C. L., Belshe, R., Talbot, H. K. B., Graham, I. L., Noah, D. L., He, F., & Hill, H. (2008) · The Journal of Infectious Diseases · doi:10.1086/527489 · Cited by 195
Wack, A., Baudner, B. C., Hilbert, A. K., Manini, I., Nuti, S., Tavarini, S., Scheffczik, H., Ugozzoli, M., Singh, M., Kazzaz, J., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2007.11.054 · Cited by 195
Structure-based design of peptides that self-assemble into regular polyhedral nanoparticles
Raman, S., Machaidze, G., Lustig, A., Aebi, U., & Burkhard, P. (2006) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2006.04.007 · Cited by 185
Pimentel, T. A. P. F., Yan, Z., Jeffers, S. A., Holmes, K. V., Hodges, R. S., & Burkhard, P. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2008.00746.x · Cited by 182
In vivo Biology and Toxicology of Fullerenes and Their Derivatives
Nielsen, G. D., Roursgaard, M., Jensen, K. A., Poulsen, S. S., & Larsen, S. T. (2008) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2008.00266.x · Cited by 179
FRAZER, I., QUINN, M., NICKLIN, J., TAN, J., PERRIN, L., NG, P., OCONNOR, V, WHITE, O., WENDT, N., & MARTIN, J. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.05.013 · Cited by 176
Henriksen‐Lacey, M., Christensen, D., Bramwell, V. W., Lindenstrøm, T., Agger, E. M., Andersen, P. L., & Perrie, Y. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.027 · Cited by 175
Kaba, S. A., Brando, C., Guo, Q., Mittelholzer, C., Raman, S., Tropel, D., Aebi, U., Burkhard, P., & Lanar, D. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901957 · Cited by 175
Look, M., Bandyopadhyay, A., Blum, J. S., & Fahmy, T. M. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.011 · Cited by 163
Klein, J. S., Gnanapragasam, P. N. P., Galimidi, R. P., Foglesong, C. P., West, A. P., & Björkman, P. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811427106 · Cited by 163
Pre-Clinical Evaluation of a Novel Nanoemulsion-Based Hepatitis B Mucosal Vaccine
Makidon, P. E., Bielinska, A. U., Nigavekar, S. S., Janczak, K. W., Knowlton, J., Scott, A. J., Mank, N., Cao, Z., Rathinavelu, S., Beer, M. R., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002954 · Cited by 159
Higaki, M., Ishihara, T., Izumo, N., Takatsu, M., & Mizushima, Y. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.030759 · Cited by 153
Eosinophils: structure and functions
Weller, P. F. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90038-8 · Cited by 145
Kaminskas, L. M., McLeod, V. M., Porter, C. J. H., & Boyd, B. J. (2012) · Molecular Pharmaceutics · doi:10.1021/mp2005966 · Cited by 143
Altering the immune response with lipid-based nanoparticles
Landesman‐Milo, D., & Peer, D. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.034 · Cited by 142
Immunodrugs: Therapeutic VLP-Based Vaccines for Chronic Diseases
Jennings, G. T., & Bachmann, M. F. (2008) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-061008-103129 · Cited by 138
Bielinska, A. U., Janczak, K. W., Landers, J. J., Makidon, P. E., Sower, L. E., Peterson, J. W., & Baker, J. R. (2007) · Infection and Immunity · doi:10.1128/iai.00070-07 · Cited by 135
Kitano, S., Kageyama, S., Nagata, Y., Miyahara, Y., Hiasa, A., Naota, H., Okumura, S., Imai, H., Shiraishi, T., Masuya, M., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1546 · Cited by 132
Uenaka, A., Wada, H., Isobe, M., Saika, T., Tsuji, K., Sato, E., Sato, S., Noguchi, Y., Kawabata, R., Yasuda, T., et al. (2007) · PubMed · Cited by 128
Scherer, E. M., Leaman, D. P., Zwick, M. B., McMichael, A. J., & Burton, D. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909680107 · Cited by 128
Tkach, A. V., Shurin, G. V., Shurin, M. R., Kisin, E. R., Murray, A. R., Young, S., Star, A., Fadeel, B., Kagan, V. E., & Shvedova, A. A. (2011) · ACS Nano · doi:10.1021/nn2014479 · Cited by 125
Recent developments in lipid-based pharmaceutical nanocarriers
Musacchio, T., & Torchilin, V. P. (2010) · Frontiers in bioscience · doi:10.2741/3795 · Cited by 123
Park, J. Y., Gao, W., Whiston, R., Strom, T. B., Metcalfe, S. M., & Fahmy, T. M. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100203a · Cited by 122
Paliard, X., Liu, Y., Wagner, R., Wolf, H. J., Baenziger, J., & Walker, C. M. (2000) · AIDS Research and Human Retroviruses · doi:10.1089/088922200309368 · Cited by 121
Kaba, S. A., McCoy, M. E., Doll, T. A. P. F., Brando, C., Guo, Q., Dasgupta, D., Yang, Y., Mittelholzer, C., Spaccapelo, R., Crisanti, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048304 · Cited by 120
Konduru, N. V., Tyurina, Y. Y., Feng, W., Basova, L., Belikova, N. A., Bayır, H., Clark, K., Rubin, M. A., Stolz, D. B., Vallhov, H., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004398 · Cited by 119
Boato, F., Thomas, R. M., Ghasparian, A., Renard, A., Moehle, K., & Robinson, J. A. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200702805 · Cited by 115
Henriksen‐Lacey, M., Christensen, D., Bramwell, V. W., Lindenstrøm, T., Agger, E. M., Andersen, P. L., & Perrie, Y. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100208f · Cited by 108
Ikuta, Y., Katayama, N., Wang, L., Okugawa, T., Takahashi, Y., Schmitt, M. W., Xiaogang, G., Watanabe, M., Akiyoshi, K., Nakamura, H., et al. (2002) · Blood · doi:10.1182/blood.v99.10.3717 · Cited by 108
Koo, O. M. Y., Rubinstein, I., & Önyüksel, H. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0330-4 · Cited by 106
Wahome, N., Pfeiffer, T., Ambiel, I., Yang, Y., Keppler, O. T., Bosch, V., & Burkhard, P. (2012) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2012.01423.x · Cited by 101
Whitmore, M., Li, S., Falo, L. D., & Huang, L. (2001) · Cancer Immunology Immunotherapy · doi:10.1007/s002620100227 · Cited by 101
Kamath, A. T., Rochat, A., Christensen, D., Agger, E. M., Andersen, P. L., Lambert, P., & Siegrist, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005771 · Cited by 101
Bal, S. M., Hortensius, S., Ding, Z., Jiskoot, W., & Bouwstra, J. A. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.11.061 · Cited by 97
Current insights in sepsis: from pathogenesis to new treatment targets
Wiersinga, W. J. (2011) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32834a4aeb · Cited by 96
Zheng, X., Vladau, C., Zhang, X., Suzuki, M., Ichim, T. E., Zhang, Z., Li, M., Carrier, E., Garcia, B. M., Jevnikar, A. M., et al. (2009) · Blood · doi:10.1182/blood-2008-04-151191 · Cited by 95
Bielinska, A. U., Janczak, K. W., Landers, J. J., et al. (2008) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2007.0148 · Cited by 94
Myc, A., Kukowska‐Latallo, J. F., Bielinska, A. U., Cao, P., Myc, P. P., Janczak, K. W., Sturm, T. R., Grabinski, M. S., Landers, J. J., Young, K. S., et al. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00381-5 · Cited by 89
Emulsion-based adjuvants for influenza vaccines
Vogel, F. R., Caillet, C., Kusters, I. C., & Haensler, J. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.5 · Cited by 88
Keijzer, C., Slütter, B., van der Zee, R., Jiskoot, W., van Eden, W., & Broere, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026684 · Cited by 88
Structure and Function of the B Cell Antigen Receptor
DeFranco, A. L. (1993) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.09.110193.002113 · Cited by 88
Stanberry, L. R., Simon, J. K., Johnson, C., Robinson, P. L., Morry, J., Flack, M., Gracon, S. I., Myc, A., Hamouda, T., & Baker, J. R. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.10.094 · Cited by 85
Self-citationWang, B., Liu, W., Kang, S., Alam, M. S., Huang, C., Ye, L., Sun, Y., Li, Y., Kothe, D. L., Pushko, P., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00542-07 · Cited by 85
Developments in virus-like particle-based vaccines for infectious diseases and cancer
Buonaguro, L., Tagliamonte, M., Tornesello, M. L., & Buonaguro, L. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.135 · Cited by 85
Babapoor, S., Neef, T., Mittelholzer, C., Girshick, T., Garmendia, A. E., Shang, H., Khan, M. I., & Burkhard, P. (2011) · Influenza Research and Treatment · doi:10.1155/2011/126794 · Cited by 84
Boyce, T. G., Hsu, H. H., Sannella, E. C., Coleman-Dockery, S. D., Baylis, E. F., Zhu, Y., Barchfeld, G. L., DiFrancesco, A., Paranandi, M., Culley, B. S., et al. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00171-7 · Cited by 81
Virus-Like Particles Induce MHC Class I-Restricted T-Cell Responses
Schirmbeck, R., Böhm, W., & Reimann, J. (1996) · Intervirology · doi:10.1159/000150482 · Cited by 79
Büyüktimkin, B., Wang, Q., Kiptoo, P. K., Stewart, J. M., Berkland, C. J., & Siahaan, T. J. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200614q · Cited by 79
Epstein-Barash, H., Gutman, D., Cohen-Sela, E., Haber, E., Elmalak, O., Koroukhov, N., Danenberg, H. D., & Golomb, G. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9060-5 · Cited by 77
Julien, J., Huarte, N., Maeso, R., Taneva, S. G., Cunningham, A., Nieva, J. L., & PAI, E. F. (2010) · Journal of Virology · doi:10.1128/jvi.02357-09 · Cited by 77
Lindell, D. M., Morris, S. B., White, M. P., Kallal, L. E., Lundy, P. K., Hamouda, T., Baker, J. R., & Lukacs, N. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021823 · Cited by 75
Structure and function of the T cell antigen receptor.
Weiss, A. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114803 · Cited by 71
Mucosal antibody response induced with a nasal virosome-based influenza vaccine
Durrer, P. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00457-2 · Cited by 71
Potent Adjuvanticity of a Pure TLR7-Agonistic Imidazoquinoline Dendrimer
Shukla, N. M., Salunke, D. B., Balakrishna, R., Mutz, C. A., Malladi, S. S., & David, S. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043612 · Cited by 71
Makidon, P. E., Knowlton, J., Groom, J. V., et al. (2009) · Medical Microbiology and Immunology · doi:10.1007/s00430-009-0137-2 · Cited by 65
Educating CD4 T cells with vaccine adjuvants: lessons from lipopolysaccharide
McAleer, J. P., & Vella, A. T. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.08.005 · Cited by 62
Mitchell, J. E., Cvetanović, M., Tibrewal, N., Patel, V. A., Colamonici, O. R., Li, M. O., Flavell, R. A., Levine, J. S., Birge, R. B., & Ucker, D. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509775200 · Cited by 61
Novel nanoparticles for the delivery of recombinant hepatitis B vaccine
Bharali, D. J., Pradhan, V., Elkin, G., Wu, Q., Hutson, A. D., Mousa, S. A., & Thanavala, Y. M. (2008) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2008.05.006 · Cited by 57
Makidon, P. E., Belyakov, I. M., Blanco, L. P., Janczak, K. W., Landers, J. J., Bielinska, A. U., Groom, J. V., & Baker, J. R. (2012) · European Journal of Immunology · doi:10.1002/eji.201142346 · Cited by 56
Engineered Synthetic Virus‐Like Particles and Their Use in Vaccine Delivery
Ghasparian, A., Riedel, T., Koomullil, J. M., Moehle, K., Gorba, C., Svergun, D. I., Perriman, A. W., Mann, S., Tamborrini, M., Pluschke, G., et al. (2010) · ChemBioChem · doi:10.1002/cbic.201000536 · Cited by 56
Richards, P. J., Williams, B. D., & Williams, A. S. (2001) · Rheumatology · doi:10.1093/rheumatology/40.9.978 · Cited by 55
The role of macrophages in the induction and regulation of immunity elicited by exogenous antigens
Wijburg, O. L. C., van den Dobbelsteen, G. P. J. M., Vadolas, J., Sanders, A., Strugnell, R. A., & van Rooijen, N. (1998) · European Journal of Immunology · Cited by 54
Mechanisms of adjuvancy: I?metal oxides as adjuvants
Naim, J. O. (1997) · Vaccine · doi:10.1016/s0264-410x(97)00016-9 · Cited by 54
Comparison of vesicle based antigen delivery systems for delivery of hepatitis B surface antigen
Vangala, A., Bramwell, V. W., McNeil, S., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.01.010 · Cited by 54
Induction of Th17 Cellular Immunity With a Novel Nanoemulsion Adjuvant
Bielinska, A. U., Gerber, M., Blanco, L. P., Makidon, P. E., Janczak, K. W., Beer, M., Swanson, B. J., & Baker, J. R. (2010) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v30.i2.60 · Cited by 52
Gaca, J. G., Palestrant, D., Lukes, D. J., Olausson, M., Parker, W., & Davis, R. D. (2003) · Journal of Surgical Research · doi:10.1016/s0022-4804(03)00142-2 · Cited by 50
A Novel, Killed-Virus Nasal Vaccinia Virus Vaccine
Bielinska, A. U., Чепурнов, А. А., Landers, J. J., Janczak, K. W., Chepurnova, T. S., Luker, G. D., & Baker, J. R. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00440-07 · Cited by 50
The preparation and safety of hepatitis B vaccine
Hilleman, M. R., McAleer, W. J., Buynak, E. B., & McLean, A. A. (1983) · Journal of Infection · doi:10.1016/s0163-4453(83)96465-4 · Cited by 47
Barata, T. S., Teo, I. A., Brocchini, S., Zloh, M., & Shaunak, S. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002095 · Cited by 41
Martínez‐Sernández, V., & Figueiras, A. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6716-y · Cited by 36
Synthetic Virus‐Like Particles and Conformationally Constrained Peptidomimetics in Vaccine Design
Riedel, T., Ghasparian, A., Moehle, K., Rusert, P., Trkola, A., & Robinson, J. A. (2011) · ChemBioChem · doi:10.1002/cbic.201100586 · Cited by 34
Baschong, W., Hasler, L., Häner, M., Kistler, J., & Aebi, U. (2003) · Journal of Structural Biology · doi:10.1016/j.jsb.2003.08.004 · Cited by 34
Chou, H.-Y., Lin, X., Pan, W., Wu, P.-Y., Chang, C., Lin, T.-Y., Shen, H.-H., & Tao, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001875 · Cited by 33
Intranasal administration of CpG DNA lipoplex prevents pulmonary metastasis in mice
Zhou, S., Kawakami, S., Yamashita, F., & Hashida, M. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.05.037 · Cited by 31
Human papillomavirus vaccine: Widening the scope for cancer prevention
No, J. H., Kim, M., Jeon, Y. T., Kim, Y., & Song, Y. S. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20657 · Cited by 29
HIV-1 Vaccine Trials: Evolving Concepts and Designs
Sanou, M., Groot, A. S. D., Murphey‐Corb, M., Levy, J. A., & Yamamoto, J. K. (2012) · The Open AIDS Journal · doi:10.2174/1874613601206010274 · Cited by 28
Emulsion-Based Adjuvants for Improved Influenza Vaccines
O’Hagan, D. T., Tsai, T. F., & Reed, S. G. (2010) · Springer eBooks · doi:10.1007/978-3-0346-0279-2_14 · Cited by 22
Nanomedicines for Inflammatory Diseases
Khaja, F., Koo, O. M. Y., & Önyüksel, H. (2012) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-391860-4.00018-5 · Cited by 20
Cited by
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
The Effect of Nanoparticle Size on In Vivo Pharmacokinetics and Cellular Interaction
Hoshyar, N., Gray, S., Han, H., & Bao, G. (2016) · Nanomedicine · doi:10.2217/nnm.16.5 · Cited by 1,990
Vaccine adjuvants: mechanisms and platforms
Zhao, T., Cai, Y., Jiang, Y., He, X., Wei, Y., Yu, Y., & Tian, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01557-7 · Cited by 1,020
Dhand, C., Dwivedi, N., Loh, X. J., Jie Ying, A. N., Verma, N. K., Beuerman, R. W., Lakshminarayanan, R., & Ramakrishna, S. (2015) · RSC Advances · doi:10.1039/c5ra19388e · Cited by 795
Synthetic Nanoparticles for Vaccines and Immunotherapy
Irvine, D. J., Hanson, M. C., Rakhra, K., & Tokatlian, T. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00109 · Cited by 763
Metadata
- Authors
- Smith, D. M., Simon, J. K., & Baker Jr, J. R.
- Venue
- Nature Reviews Immunology
- Published
- 2013-07-25
- Volume
- 13
- Issue
- 8
- Pages
- 592-605
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1965235573
- Cited by
- 767
- References
- 130
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.